(Q70391307)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132343%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132343%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

author name string

M Zöller

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132343%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

publication date

1 September 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132343%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

10 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132343%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132343%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132343%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

411-429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132343%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01760576

10 October 2019

exact match

0 references

cites work

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

1 reference

12 December 2020

Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6.

1 reference

12 December 2020

Recombinant interferon-gamma (immuneron): results of a phase I trial in patients with cancer

1 reference

12 December 2020

Immuno-selection in vivo of H-2D phenotypic variants from a metastatic clone of sarcoma cells results in cell lines of altered metastatic competence

1 reference

12 December 2020

Interferon-mediated protection of B16 melanoma cells from cytotoxicity by activated macrophages

1 reference

12 December 2020

Low doses of interferon alpha result in more effective clinical natural killer cell activation

1 reference

12 December 2020

NK susceptibility varies inversely with target cell class I HLA antigen expression.

1 reference

12 December 2020

Recombinant interferon-gamma increases HLA-DR synthesis and expression

1 reference

12 December 2020

Activation of human macrophages. Comparison of other cytokines with interferon-gamma

1 reference

12 December 2020

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

1 reference

12 December 2020

Biological response modifiers: their potential and limitations in cancer therapeutics

1 reference

12 December 2020

Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.

1 reference

12 December 2020

Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma

1 reference

12 December 2020

Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.

1 reference

12 December 2020

Mechanisms of macrophage activation by corynebacterium parvum. II. In vivo experiments

1 reference

12 December 2020

Heterogeneity of murine mammary adenocarcinoma cell subpopulations. In vitro and in vivo resistance to macrophage cytotoxicity and its association with metastatic capacity.

1 reference

12 December 2020

Effects of a cloned cell line with NK activity on bone marrow transplants, tumour development and metastasis in vivo

1 reference

12 December 2020

Interferon-gamma treatment of B16 melanoma cells: opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread

1 reference

12 December 2020

Natural killer cells kill tumour cells at a given stage of differentiation

1 reference

12 December 2020

Interferons: biochemical, cell growth inhibitory, and immunological effects

1 reference

12 December 2020

Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell

1 reference

12 December 2020

Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferon.

1 reference

12 December 2020

Effect of interferon-gamma on class-II antigen expression and accessory cell function

1 reference

12 December 2020

Anti-tumor activity of class II MHC antigen-restricted cloned autoreactive T cells. I. Destruction of B16 melanoma cells mediated by bystander cytolysis in vitro

1 reference

12 December 2020

A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer

1 reference

12 December 2020

A Rapid Method for the Separation of Functional Lymphoid Cell Populations of Human and Animal Origin on PVP-Silica (Percoll) Density Gradients

1 reference

12 December 2020

Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin

1 reference

12 December 2020

Differential effects of interferon on the expression of H-2K, H-2D, and Ia antigens on mouse lymphocytes

1 reference

12 December 2020

Interferons with Special Emphasis on the Immune System

1 reference

12 December 2020

HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes

1 reference

12 December 2020

Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice

1 reference

12 December 2020

Lymphokine dependence of in vivo expression of MHC class II antigens by endothelium

1 reference

12 December 2020

Macrophages in cancer metastases and their relevance to metastatic growth

1 reference

12 December 2020

Differential expression of H-2 gene products in tumour cells in associated with their metastatogenic properties

1 reference

12 December 2020

Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens

1 reference

12 December 2020

Effect of interferons on the inhibition of human natural killers by primary monolayer cell cultures

1 reference

12 December 2020

Rat macrophages inhibit natural killer (NK) cell activity against adherent growing target cells

1 reference

12 December 2020

Induction of antigen presentation ability in purified cultures of astroglia by interferon-gamma.

1 reference

12 December 2020

The effect of gamma-interferon on MHC antigens

1 reference

12 December 2020

Astrocytes present myelin basic protein to encephalitogenic T-cell lines

1 reference

12 December 2020

Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells

1 reference

12 December 2020

Evaluation of in vivo and in vitro effectivity of immune defense against a spontaneously arising, nonlymphoid rat tumor. I. Analysis of natural immune defense

1 reference

12 December 2020

Role of natural killer cells in control of cancer metastasis.

1 reference

12 December 2020

Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine

1 reference

12 December 2020

Biologicals and biological response modifiers: new approaches to cancer treatment

1 reference

12 December 2020

Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes

1 reference

12 December 2020

Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease

1 reference

12 December 2020

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

12 December 2020

Mode of regulation of natural killer cell activity by interferon

1 reference

12 December 2020

The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors

1 reference

12 December 2020

Direct and indirect effects of interferon on in vivo murine tumor cell growth.

1 reference

12 December 2020

Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells

1 reference

12 December 2020

Phase I study of i.v. administered recombinant gamma interferon in cancer patients

1 reference

12 December 2020

Normally occurring inhibitory cells for natural killer cell activity. I. Organ distribution

1 reference

12 December 2020

Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity

1 reference

12 December 2020

Metastatic capacity of cloned T10 sarcoma cells that differ in H-2 expression: inverse relationship to their immunogenic potency

1 reference

12 December 2020

Origin and specificity of autoreactive T cells in antigen-induced populations

1 reference

12 December 2020

Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing

1 reference

12 December 2020

Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2

1 reference

12 December 2020

Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon

1 reference

12 December 2020

Interferon-mediated protection of normal and tumor target cells against lysis by mouse natural killer cells.

1 reference

12 December 2020

Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide

1 reference

12 December 2020

Interferons in the treatment of human cancer

1 reference

12 December 2020

Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents

1 reference

12 December 2020

Natural cytotoxicity in lymphatic metastasis. I. In vitro studies using the rat tumor BSp73 and its variants

1 reference

12 December 2020

The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.

1 reference

12 December 2020

Interferon as a biological response modifying agent in clinical trials

1 reference

12 December 2020

Enhanced NK cell activity in mice injected with interferon and interferon inducers

1 reference

12 December 2020

Regulation of natural killer cell activation: implementation for the control of tumor metastasis

1 reference

12 December 2020

Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01760576

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3132343%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference